Murer, P., Brannetti, B., Rondeau, J., Petersen, L., Egli, N., Popp, S., . . . Huber, C. Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMurer, Patrizia, et al. Discovery and Development of ANV419, an IL-2/anti-IL-2 Antibody Fusion Protein with Potent CD8+ T and Natural Killer Cell-stimulating Capacity for Cancer Immunotherapy. Taylor & Francis Group.
MLA (9th ed.) CitationMurer, Patrizia, et al. Discovery and Development of ANV419, an IL-2/anti-IL-2 Antibody Fusion Protein with Potent CD8+ T and Natural Killer Cell-stimulating Capacity for Cancer Immunotherapy. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.